© NuAge Vision 2014 Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 Creating.

Slides:



Advertisements
Similar presentations
Managing Intellectual Property Assets in International Business Anil Sinha, Counsellor, SMEs Division World Intellectual Property Organization (WIPO)
Advertisements

2nd Panel, Best Practices: “ IPR in Successful University-Industry Collaborations” Dr. Tamar Raz, CEO Hadasit, the Technology Transfer Company of Hadassah.
Back to Table of Contents
Do You Want to Start a Company? or Lessons from Babs’s Excellent Adventure Babs Soller, PhD Founder, President & Chief Scientific Officer Reflectance Medical.
BUSINESS YOUR BUSINESS About us Services Contact SOLUTIONS Professional SOLUTIONS GROWTH Supporting the GROWTH of Why work with us?
What is Biotech YES?. “an innovative competition developed to raise awareness of the commercialisation of bioscience ideas among postgraduate students/postdoctoral.
© 2005 Morrison & Foerster LLP All Rights Reserved How to Launch a Successful IPO Avoiding Disappointment and Unnecessary Costs Bruce Alan Mann Partner,
LOWER SHORE TECHNOLOGY TRANSFER SYMPOSIUM Bringing the Benefits of Discovery to the World MAY 23, 2012 Wesley D. Blakeslee Executive Director Johns Hopkins.
Creating and Commercializing your Patent Portfolio “Supersize” your profitability! Naomi Assia & Co. – Law Offices, Patent Attorney’s and Notary © Copyright.
Biotechnology Incubators in Israel. The Israeli Biotechnology Market 160 companies (30% in therapeutics) 4000 employees Market valuation: $3.5 billion.
Technology Transfer University of Colorado Denver Rick Silva, Ph.D., M.B.A. -- Director Senior Licensing Managers David Poticha, M.S., J.D. Paul Tabor,
Intellectual Property Patent Primer Michael Pratt Executive Director, Business Development November 1, 2011.
© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Strategic.
© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Developing.
Intellectual Property – Why it Matters
Private Equity Fund Structure - Best Practices June 24 th, 2014.
Intellectual Property Portfolios in Business Strategy 22 th of February 2002 Innovation and Knowledge Management Anabela Piedade Ana Sofia Mascarenhas.
© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Optimizing.
An Enterprising University Roger Ford Chair of Innovation and Technology Strategy.
Iowa State University Research Foundation, Inc. (ISURF) and the Office of Intellectual Property and Technology Transfer (OIPTT) Kenneth Kirkland, Executive.
PowerPoint Presentations for Small Business Management: Launching and Growing New Ventures, Fifth Canadian Edition Adapted by Cheryl Dowell Algonquin College.
OMPI, Aprli 2005Athelas SA Copyright STARTUPS, IP AND ALL THAT SORT OF THINGS IP issues as seen from the limited perspective of a startup company active.
Entrepreneurial Mindset and Main Topics in a Sustainable Business Plan By Gonzalo Manchego Business Consultant.
© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) The three.
Improving Animal and Human Health by Accelerating Veterinary Centered Entrepreneurship.
© 2014 Foley Hoag LLP. All Rights Reserved. International Patent Protection for Emerging Companies WIPO Program on International IP Protection Suffolk.
A powerful, unique (patent pending) website that pulls together everything businesses and projects need for success: Crowdsourcing Crowdfunding Social.
The use of patents by a university spin-off. Sub-module BThe use of patents by a university spin-off 2/21 Structure of the case study University technology.
Part 4 PowerPoint Presentation by Charlie Cook Copyright © 2003 South-Western College Publishing. All rights reserved. All rights reserved. The Role of.
University Startup Best Practices Presentation for Technology Transfer Tactics April 15 th, 2009.
Product/Service Name: Team Leader: Faculty / Research Alliance: Mobile Tel:
New Product Development (NPD) 3 inescapable facts about NPD – It is expensive, risky and time consuming For example, Gillette spent in excess of £100 million.
Overview OTL Mission Inventor Responsibility Stanford Royalty Sharing Disclosure Form Patent View Inventor Agreements Patent.
Business Plan Teaser For your company XSEEDCapital GmbH ®2014 XSEEDCapital.
Commercialisation of Research Igor Skryabin Business Development Manager CSES.
Commercialisation at Griffith Dorina Caccamo Manager, Contracts and Administration Griffith Enterprise Value through.
A Dual Role Principal (Rector) of Heriot-Watt University Chair of the regional economic development company.
PROMOTING TECHNOLOGY TO INDUSTRY Technology transfer objectives: enhance commercial value of invention promote technology to partner / investor identify.
Polimi Case study: Procedures, tools, facts & Figures
“Inventing the Future” – The Role of Utility Models and Patents in Leveraging Technical Innovation in the Market Place Kingston, Jamaica Jun 4 - 6, 2012.
Integrating Innovation
Page 1 IOP Genomics Workshop Patents and Patenting Biotech Inventions Annemieke Breukink, Ph.D. September 8th, 2009.
Market Health SOME CONCLUDING REMARKS. This project has received funding from the European Union’s Seventh Framework Programme for research, technological.
Dr Caroline Barelle MBA Giving birth to a biotech where’s the pain relief ?!
Australian Technology Innovation Fund Limited Your entry into the lucrative biotech market Australian Technology Innovation Fund Limited Prospectus presentation.
SEEKING INVESTORS Investment Opportunity LPG and Butane Gas Engine Conversion Kits.
11-1 Copyright © 2010 Pearson Education, Inc. publishing as Prentice Hall Part IV: Start-up Financial Strategy Chapter 11: Funding the Technology Start-up.
Intellectual Property Rights and Pharmaceutical Industry
THE IMPORTANCE OF IPR ACROSS THE LIFECYCLE OF INNOVATION Bob Stembridge Principal Patent Analyst, IP & Science.
© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Innovation.
Score IP update Paul H. Riley Score Project Director.
Business Plans Part 2 Taken from
Industry’s Perspective on Industry-University Intellectual Property External Research Directors Network Industrial Research Institute, Inc. April 17, 2001.
Negotiating the Deal. New Venture Story Short narrative of factual or imagined events Emphasizes goals and merits of venture through the story Often personal.
Building the Best Team that Delivers and that Investors Love TEAMWORK MAKES THE DREAM WORK:
Patent Review Overview Summary of different types of Intellectual Property What is a patent? Why would you want one? What are the requirements for patentability?
[Business/Concept Name] [Presenter, Key Personnel] ***Remember as you draft your slides that there is a hard 12 minute stop on your presentation***
Chapter 9- slide 1 Copyright © 2010 Pearson Education, Inc. Publishing as Prentice Hall Observing a marketplace and make a report on it - New market, Gawsia,
IP4INNO Module 4B: Business Planning with IP The 7Ps Assessment Tool Timing recommendation: 1.5 hours Name of speakerVenue & date.
Skolkovo PRESENTATION
Single Cell Analysis Systems for Therapeutic Discovery
Foresight Science & Technology, Inc.
Technology Commercialization & Industry Partnering
Angel Investing 201 Stages of investing Why a Portfolio?
Patents, Cannabis, and the Current U.S. Climate
THE TRIANGLE: TTO- ACADEMICIAN-VC
Accredited investors investing in early stage companies
Buy and Build Strategy- Keys to Success
Accredited investors investing in early stage companies
Accredited investors investing in early stage companies
Presentation transcript:

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Creating and Running Companies Bruce Savage BioQuest Consulting  What do I do?  Work with scientific founder/university to write business plan, raise investment and run the business on part time basis  I am currently on start up no 8  Have raised £14m

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Critical issues in running a successful company  Credible, realistic business plan  Strong focus on how co will make money and how it will give investors a good return  Raising adequate investment  Experienced management  Strong, clean IP with a plan to increase patent portfolio

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Comments on IP  Investors invest in your patents – your major asset  BUT looking for quality  patents in application do not have same value as granted patents  A good examination report can help with investment  Road to obtaining a granted patent can be long and expensive and risky  A freedom to operate search can help investors confidence

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) How to build real value  Substantiate claims  Reduce to practice  Build a portfolio around core patent  Demonstrate real commercial value of IP by showing strong growth in sales of patent protected products

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Cytocell Molecular diagnostics company detection of genetic diseases  Sold products worldwide through distributors  98% sales outside UK  Core technology – through collaboration and sought licensing deals  IP problems principally in US  In licensed main product from Univ Oxford

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) BioAnalab  Spin out from Univ Oxford – service company with pharma companies as customers  Strong growth in sales through  Web site  Conferences  Business development exec.  Know-how (SOP’s) but not patents licensed from university  Great deal of know-how in complex field

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) CMP Therapeutics  Novel treatment for allergies based on natural product  IP assigned (not licensed) from Medical Research Council  Commercialisation through license deals once efficacy shown in clinical trials  IP issues in US but solved by inventor meeting USPO

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) GFC Diagnostics  Test kits to detect smoking – insurance industry and hospital customers  Sales generated mainly through web site - worldwide and some personal selling  Initial patent on device lapsed but new patent filed on new chemistry, granted in US with no issues!!  Patent filing fees big cost  Strong growth in sales

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Summary  A granted patent really helps raise investment but there are other important considerations  Business plan must have a focus on a realistic commercialisation plan with a credible exit strategy.  Good management with experienced sales and marketing team  Good luck – especially with US patent office!